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 ABSTRACT 
 Absorption of adequate IgG from colostrum is criti-
cal to provide the newborn calf with adequate immuno-
logical protection and resistance to disease. Excessive 
iodine supplementation of the prepartum ewe reduces 
IgG absorption of her offspring; it is possible that exces-
sive iodine supplementation of the prepartum dairy cow 
may similarly impair the ability of the calf to acquire 
immunological protection. The objectives of this study 
were to determine whether the iodine status, health sta-
tus, and ability of calves to absorb IgG from colostrum 
were affected by prepartum iodine supplementation 
strategies of their dams. Dairy cows (n = 127) received 
one of the following levels of iodine supplementation 
precalving: 15 mg of iodine/kg of dietary dry matter 
(DM) (HI); no additional iodine supplementation (MI); 
5 mg/kg of dietary DM (SI); and 15 mg of iodine/kg 
of DM for the first 3.5 wk of the precalving period and 
no additional supplementation for the second 3.5 wk 
(HMI). Calves were assigned to 1 of 6 experimental 
treatments, based on the prepartum iodine supple-
mentation treatment of their dam and the precalving 
treatment group of the cows from which the colostrum 
fed was obtained: (1) HI_HI: born to HI dams, fed HI 
colostrum (i.e., colostrum produced by cows in the HI 
group); (2) MI_MI: born to MI dams, fed MI colos-
trum; (3) SI_SI: born to SI dams, fed SI colostrum; (4) 
HI_MI: born to HI dams, fed MI colostrum; (5) MI_HI: 
born to MI dams, fed HI colostrum; and (6) HMI_HMI: 
born to HMI dams, fed HMI colostrum. Concentration 
of calf serum IgG and plasma inorganic iodine (PII) 
was measured at 0 and 24 h of age. Apparent efficiency 
of absorption for IgG was determined. Health scores 
were assigned to calves twice weekly and all episodes 
of disease were recorded. Cow experimental treatment 
group affected calf PII at 0 h of age; the PII of calves 
born to HI dams (987.2 μg/L) was greater than that of 
calves born to MI dams (510.1 μg/L), SI (585.2 μg/L), 
and HMI dams (692.9 μg/L). Calf experimental treat-
ment group affected calf PII at 24 h of age; the PII of 
HI_HI (1,259.2 μg/L) and HI_MI (1,177.8 μg/L) calves 
was greater than MI_MI (240.7 μg/L), SI_SI (302.2 
μg/L), HMI_HMI (320.7 μg/L), and MI_HI (216.3 
μg/L) calves. No effect of experimental treatment 
was observed on the concentration of IgG measured 
in calf serum at 24 h of age, or on apparent efficiency 
of absorption. Experimental treatment had no effect 
on the likelihood of a calf being assigned a worse na-
sal, eye and ear, cough, or fecal score within the study 
period, nor did it affect the probability of a calf receiv-
ing treatment for a disease a greater number of times. 
Prepartum iodine supplementation of cows at 15mg/
kg of DM increased the iodine levels in their calves at 
birth and 24 h of age, but did not affect their ability 
to absorb IgG from colostrum. Supplementation with 
iodine above the minimum requirements established 
by the National Research Council was unnecessary to 
ensure appropriate iodine levels in calves at birth. 
 Key words:   calf ,  colostrum ,  immunoglobulin G ,  io-
dine 
 INTRODUCTION 
 Absorption of sufficient IgG provides the neonatal 
calf with vital immunological resistance to combat dis-
ease and has been shown to have numerous short- and 
long-term benefits. These benefits include reduced risk 
of pre- and postweaning morbidity and mortality, im-
proved rate of weight gain and feed efficiency, as well as 
greater milk production and longevity within the herd 
(Robison et al., 1988; DeNise et al., 1989). The transfer 
of immunoglobulins from the dam to the neonatal calf 
is termed passive transfer. Adequate passive transfer is 
said to have occurred if the IgG level in the serum of 
the calf is ≥10 g/L when sampled between 24 and 48 h 
of age (Besser et al., 1991). 
 Recent studies and surveys indicate inadequate 
transfer of passive immunity occurs in a high propor-
tion of neonatal calves internationally (USDA, 2007; 
Trotz-Williams et al., 2008; DAFM, 2011; Panousis et 
al., 2013). This suggests that inadequate absorption of 
IgG from colostrum may be an important contributory 
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factor to the high mortality rate of calves worldwide, 
including Ireland (5.1% calves dead in the first 12 mo 
of life, excluding stillbirths; DAFM, 2012). Failure of 
passive transfer in the neonatal calf may occur for sev-
eral reasons, including (1) ingestion of an insufficient 
volume of colostrum, (2) ingestion of colostrum during 
the period when the neonatal gut is no longer capable 
of absorbing IgG, and (3) ingestion of colostrum con-
taining an inadequate concentration of IgG (Godden, 
2008). Other factors may also reduce the capacity of 
the neonatal intestine to absorb IgG; previous studies 
have demonstrated that high levels of iodine fed to ewes 
in late pregnancy can impair the ability of their lambs 
to absorb IgG from colostrum, due to a preprogrammed 
decrease in absorption ability (Boland et al., 2004; 
Crosby et al., 2004; Boland et al., 2008).
Supplementation of the prepartum dairy cow diet 
with iodine is standard practice across most dairy 
farms. However, in many cases it is possible that cows 
are being supplemented with a level higher than the 
maintenance iodine requirement established by the 
NRC (requirement of the pregnant nonlactating cow 
is 0.33 mg of iodine/kg of dietary DM; NRC 2001), al-
though definitive data are lacking at present to confirm 
this. Further supplementation is unnecessary and has 
the potential to cause a state of toxicity and consequent 
harmful effects, including an increase in reproductive 
disorders (Paulíková et al., 2002), excessive nasal and 
ocular discharge, salivation, decreased milk production, 
coughing, dry and scaly coats (Olson et al., 1984), and 
suppression of the immune system (Hillman and Curtis, 
1980). Furthermore, excessive iodine supplementation 
of the prepartum cow may negatively affect the transfer 
of immunity from dam to calf if the same phenomenon 
that has been demonstrated to occur in sheep (Boland 
et al., 2004; Crosby et al., 2004; Boland et al., 2008) 
occurs in cattle.
Whether inadequate absorption of IgG results from 
over-supplementation of iodine in the pregnant cow is 
presently unclear. Gilles et al. (2009) and Rose et al. 
(2012) reported no reduced absorption of IgG in calves 
of dams supplemented with iodine; however, both these 
studies used a bolus as a means of iodine supplementa-
tion and limited studies have examined the effects of 
providing mineral supplementation via a powder, which 
delivers a specific quantity of iodine on a daily basis. 
In addition, varying levels of iodine supplementation 
used in the studies by Gilles et al. (2009) and Rose et 
al. (2012) means it remains uncertain whether the same 
phenomenon that has been demonstrated in sheep also 
occurs in cattle.
Therefore, the objectives of the present study were 
to determine (1) the effects of offering varying levels 
of supplementary iodine to cows during the last 7 wk 
of pregnancy on the serum IgG concentration, plasma 
inorganic iodine (PII) concentration, and health pa-
rameters of their calves; (2) the effects of timing of 
iodine supplementation of cows and heifers during the 
precalving period on the serum IgG concentration, PII 
concentration, and health parameters of their calves; 
and (3) whether any reduction in the serum IgG con-
centration of the calves was mediated through a pre-
programming of the calf with an impaired absorptive 
ability or through an effect on the colostrum itself.
MATERIALS AND METHODS
The current study was conducted from December 
13, 2011, to June 19, 2012, at the Teagasc Moorepark 
Research farm located in County Cork, in southern Ire-
land (52°9cN, 8°16cW). One hundred twenty-seven dairy 
cows were used to provide calves for the study. In total, 
48 first parity animals were used, and 37, 18, 11, and 13 
cows in their second, third, fourth, and fifth or greater 
parity, respectively.
Iodine Supplementation of Cows and Heifers
Seven weeks before their respective calving due date 
(i.e., at dry-off for cows), animals were stratified based 
on breed, parity, and calving date and randomly as-
signed, within stratum, to 1 of 4 precalving treatment 
groups. The 4 groups were based on the level of iodine 
supplementation of the precalving diet as (1) high iodine 
supplementation (HI; 15 mg of iodine/kg of dietary 
DM, 3 times the current European Union maximum 
permitted limit); (2) maintenance iodine (MI; no ad-
ditional iodine supplementation, although the diet was 
formulated to ensure that maintenance iodine require-
ment was satisfied; the maintenance iodine requirement 
of the pregnant nonlactating cow is 0.33 mg of iodine/
kg of dietary DM; NRC 2001); (3) standard iodine (SI; 
supplementation at 5 mg of iodine/kg of dietary DM, 
the current European Union maximum permitted level 
of iodine); and (4) high to maintenance iodine (HMI; 
supplemented at the HI level for the first 3.5 wk of the 
dry period and the MI level for the last 3.5 wk; Table 
1).
Cow Management and Diet
Following dry-off, cows were housed in a cubicle shed 
in their separate treatment groups and fed a TMR diet 
ad libitum, which consisted of 3 kg of dry cow con-
centrate, 2 kg of straw, 33 to 40 kg of silage (depend-
ing on the DM%), and 0.25 g of molasses per cow per 
day (on a fresh weight basis). Fresh TMR was offered 
daily and the refused feed was removed every second 
5122 CONNEELY ET AL.
Journal of Dairy Science Vol. 97 No. 8, 2014
day. Late gestation cows were moved into individual 
straw-bedded calving pens before calving. Mineral 
powders were specially formulated (Table 2) to contain 
the specified quantity of iodine for each experimental 
group to ensure that the desired quantities of iodine 
and other minerals could be delivered when offered at 
a rate of 100 g/cow per day (Multitrace Pre-calver, 
Inform Nutrition Ireland, Whites Cross, Cork, Ireland). 
The mineral powder was topically applied to the TMR 
twice daily. Fresh water was available at all times.
Experimental Treatments of Calves
The resulting calf study population consisted of 128 
dairy calves (59 female and 69 male) consisting of 68 
Holstein-Friesian, 50 Jersey × Holstein-Friesian, and 10 
Holstein-Friesian × Norwegian Red. The median date 
of birth of the calves was February 6; mean calf BW at 
birth was 35.9 kg (SD 6.1). Calves were assigned to 1 
of 6 experimental treatment groups (Figure 1) based on 
the level of prepartum iodine supplementation of their 
dam and the origin of the colostrum they received (i.e., 
the precalving treatment group of the cow or cows from 
which the colostrum fed was obtained). The experimen-
tal treatments were: (1) high iodine (HI_HI; born to 
HI dams, fed HI colostrum; i.e., colostrum produced by 
cows in the HI group); (2) maintenance iodine (MI_
MI; born to MI dams, fed MI colostrum); (3) standard 
iodine (SI_SI; born to SI dams, fed SI colostrum); (4) 
high iodine crossover (HI_MI; born to HI dams, fed 
MI colostrum); (5) maintenance I crossover (MI_HI; 
born to MI dams, fed HI colostrum); and (6) high to 
maintenance I (HMI_HMI; born to HMI dams, fed 
HMI colostrum).
Colostrum Feeding and Management  
of Calves at Calving
All calving events were attended and observed by 
competent and trained personnel. To ensure the calf did 
not suckle its dam before feeding of colostrum or blood 
sampling (detailed below), the calf was separated from 
the dam before it became ambulatory. Each calf was 
weighed (TruTest XR 3000, Tru-test Limited, Auck-
land, New Zealand) and a blood sample was obtained 
(detailed below). The calf was then fed colostrum (8.5% 
of BW) according to its experimental treatment group.
If possible, the colostrum fed to each calf at the ini-
tial feed following birth was colostrum obtained from 
the first milking postcalving of its own dam (except for 
calves assigned to the HI_MI or MI_HI treatments). If 
it was not possible to feed the calf colostrum from its 
own dam, the calf was fed colostrum obtained from one 
of the other recently calved cows from the same iodine 
supplementation group. All initial feeds of colostrum 
were administered via an oresophageal tube.
Each calf was then placed in an individual pen, mea-
suring 0.8 × 1.2 m, where it remained for 3 d and 
received 4 feeds of transition milk, which were pooled 
from the second milking postcalving of recently calved 
cows from their respective treatment group. All subse-
quent feeds were given by nipple bottle, and the quan-
tity fed at each feeding was 2 L. Pooled transition milk 
was retained for a maximum of 2 d, after which it was 
discarded and a new batch was created. The subsequent 
transition milk feeds were given at the next standard 
feeding times (0800 and 1500 h) unless a calf was born 
Table 1. Level of iodine provided by the basal diet and supplementation, total iodine intake, and relationship to requirements and toxicity for 
cows of the high iodine (HI), maintenance iodine (MI), standard iodine (SI), and high to maintenance (HMI) experimental treatments 
Cow experimental  
treatment
Level of iodine  
supplementation  
(mg/kg of DM)
Iodine from  
basal diet  
(mg/kg of DM)
Total daily 
iodine intake1  
(mg/d)
Relationship to 
requirement2  
(times requirement)
Relationship to 
toxicity3  
(times toxicity)
HI 15 0.33 165.7 46 3.3 
MI — 0.33 3.6 1 1/14
SI 5 0.33 57.6 16 1.15 
HMI
 First 3.5 wk of the dry period 15 0.33 165.7 46 3.3
 Second 3.5 wk of the dry period — 0.33 3.6 1 1/14
1Total iodine intake was calculated assuming an average cow BW of 600 kg and a DMI of 1.8% of BW per cow per day.
2Toxicity level of iodine is 50 mg/d (NRC, 2001).
3The iodine requirement of the pregnant, nonlactating cow is 0.33 mg/kg of DM.
Table 2. Composition of mineral supplement used in dry-cow diet 
Item Quantity (per 100 g of mineral supplement)
Magnesium (g) 17 
Iodine Varied according to treatment
Selenium (mg) 6 
Copper (mg) 400
Manganese (mg) 125
Cobalt (mg) 9.9
Zinc (mg) 500
Vitamin A (IU) 27,500
Vitamin D (IU) 750
Vitamin E (IU) 50 
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within the 3 h before the next standard feeding time. In 
this case, the subsequent transition milk feed was given 
at the following standard feeding time. A sample from 
both the first milking colostrum and the transition milk 
fed to each calf was taken for subsequent IgG analysis. 
These samples were stored at −20°C until analysis.
Management of Calves Postcolostrum  
and Transition Milk Feeding
Following feeding of transition milk, calves were 
moved to a group pen of 16 animals; the largest dif-
ference in birth date within group was 2 wk. Bulls 
and heifers were housed in separate pens. Heifer calves 
remained in the group pen until they were turned out 
to pasture at 4 wk of age, where they grazed in groups 
of 16 calves per 0.8-ha paddock. Bull calves were sold 
between 3 and 4 wk of age.
Calves were fed whole milk twice a day at a daily 
rate of 15% of birth BW/calf until 3 wk of age, when 
they received the same quantity in a once-daily feed. 
Heifer calves were weaned once they had attained spe-
cific target weights for their breed (90 kg for Holstein-
Friesian, 80 kg for Holstein-Friesian × Norwegian Red, 
75 kg for Jersey × Holstein-Friesian). The calves were 
then removed from the group of calves with which they 
were grazing and gradually weaned during the following 
week. All calves were managed similarly postweaning 
and had full-time access to pasture plus 1 kg (fresh 
weight) of supplementary concentrate feed offered per 
day.
Fresh water was available at all times and ad libitum 
concentrate and hay were offered from 4 d of age. The 
general health of the calves was monitored twice daily 
by an on-site veterinarian; any animal that became ill 
received the appropriate care and veterinary treatment 
as required.
Data Collection and Analysis
Collection of Calf Serum and Plasma. Two 
6-mL blood samples were taken from the jugular vein 
of each calf within 1 h of birth, before feeding colos-
trum (0 h): 1 sample into a plain serum tube and 1 
sample into a lithium heparin tube (BD Vacutainer, 
Lagenbach, Germany). Two further blood samples 
were taken again from each calf at 24 h of age. Blood 
collected in lithium heparin tubes was separated by 
centrifugation at 3,500 × g for 30 min at 4°C within 
2 h of collection to obtain plasma; samples collected 
in plain serum tubes were refrigerated for 24 h before 
serum was separated by centrifugation at 3,500 × g for 
30 min at 4°C. Both serum and plasma were frozen at 
−20°C before determination of serum IgG and plasma 
inorganic iodine concentration determination.
Laboratory Analysis of Serum, Colostrum, 
and Plasma. The IgG concentration in serum and 
colostrum was determined by the ELISA method (Bo-
vine IgG ELISA Kit Cat. No. 8010, Alpha Diagnostic 
International, San Antonio, TX). Samples were assayed 
in duplicate with an interassay CV of 0.15. The concen-
tration of IgG in samples was calculated from a stan-
dard reference curve containing known concentrations 
of IgG. Any sample that resulted in an IgG concentra-
tion that fell outside the range of the standard refer-
ence curve was retested after further dilution according 
Figure 1. Division of cows and calves into experimental treatment groups. Arrows indicate the origin of the colostrum fed to each calf ex-
perimental treatment group. HI = high iodine; MI = maintenance iodine; SI = standard iodine; HMI = high to maintenance iodine; HI_HI = 
born to HI dams, fed HI colostrum; MI_MI = born to MI dams, fed MI colostrum; SI_SI = born to SI dams, fed SI colostrum; HI_MI = born 
to HI dams, fed MI colostrum; MI_HI = born to MI dams, fed HI colostrum; HMI_HMI = born to HMI dams, fed HMI colostrum.
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to the test recommendations. The PII concentration 
was determined by using ion-exchange chromatography 
(Aumont and Tressol, 1987).
Collection of Calf Health Data. Individual ani-
mal health scores were assigned to calves on a twice-
weekly basis by a single veterinarian. Heifer calves were 
scored from birth until weaning at approximately 12 
wk of age; scores were assigned to male calves from 
birth until 3 to 4 wk of age. Health scores were as-
signed using a calf health-scoring system developed by 
the School of Veterinary Medicine, University of Wis-
consin-Madison (http://www.vetmed.wisc.edu/dms/
fapm/fapmtools/8calf/calf_health_scoring_chart.pdf). 
Calves were scored on 4 different aspects of health: 
nasal, eye and ear, fecal, and cough. Each individual 
aspect received a score from zero to 3; zero representing 
normal and 3 representing the most severely affected.
Collection of Calf Disease Data. All calves were 
examined twice daily by an on-farm veterinarian. As-
sessment was made of general demeanor, fecal consis-
tency, and respiratory rate. Calves were examined to 
determine the presence of a cough and nasal and ocular 
discharge. Any calf that was exhibiting any abnormal 
clinical sign was subjected to a complete clinical exami-
nation that included determination of temperature and 
auscultation of the lungs. Any animal that became ill 
received the appropriate care and veterinary treatment, 
if required, and all episodes of disease and treatments 
were recorded. The decision as to whether a disease 
episode was severe enough to necessitate treatment and 
the type and duration of treatment required was made 
by the farm veterinarian in consultation with the farm 
manager. Calves that died during the study period (n = 
6) were subject to routine necropsy examination.
Determination of Apparent Efficiency of Ab-
sorption. Apparent efficiency of absorption (AEA) 
estimates the efficiency of immunoglobulin absorption 
before cessation of intestinal absorption of immuno-
globulins (Quigley et al., 1998). Apparent efficiency 
of absorption of IgG was determined as previously de-
scribed (Quigley et al., 1998, 2002) using the following 
formula:
AEA = [serum IgG (g/L) × plasma volume  
(L)/IgG intake (g)] × 100.
The plasma volume was calculated as plasma volume = 
0.089 × (BW at birth, kg) (Quigley et al., 1998).
Data Editing and Statistical Analysis
IgG of Colostrum Fed to Calves. A fixed effects 
model in PROC GLM (SAS version 9.3, SAS Institute 
Inc., Cary, NC) was used to establish whether the IgG 
concentration of the colostrum fed to calves at the first 
feeding after birth or the total mass of IgG fed to each 
calf in the first 24 h of life differed between experi-
mental treatment groups. The independent variable in 
both cases was experimental treatment group of calf. 
Concentration of IgG in colostrum fed to calves was 
normally distributed, as was the total mass of IgG fed 
to each calf in the first 24 h of life.
Calf Serum IgG and AEA. Concentration of IgG 
in the calf serum was normally distributed. The AEA 
was calculated for 117 of the 128 calves; data required 
to calculate AEA were missing for 11 of the 128 calves, 
so these were excluded from the analysis. Mixed models 
in PROC MIXED (SAS version 9.3) were used to de-
termine the effect of experimental treatment on serum 
IgG concentrations at 0 and 24 h of age. Independent 
variables considered for inclusion in the model included 
experimental treatment group of the calf and age of the 
calf when serum was sampled (0 and 24 h). Interac-
tions between the experimental treatment group of calf 
and age of calf were also considered in the model. Calf 
was included as a repeated effect and heterogeneous 
variances were assumed among records. A fixed effects 
model in PROC GLM (SAS version 9.3) was used to 
establish whether the experimental treatment group 
of calf affected the AEA of IgG at 24 h of age. The 
independent variable in the model was experimental 
treatment group of calf.
Because feeding of the subsequent transition milk 
feeds took place at fixed times during the day (0800 
and 1500 h), and because of the spread in the actual 
times of birth of each calf, variation existed in the 
number of subsequent transition milk feeds each calf 
received before cessation of IgG absorption at 24 h of 
age depending on their time of birth. Thus, the time 
of birth of the calf was considered as a covariate also. 
Time of birth of the calf was categorized as (1) calf 
born between 0500 and 0800 h, next transition milk 
feed at 1500 h; (2) calf born between 0800 and 1200 
h, next transition milk feed at 1500 h; (3) calf born 
between 1200 and 1500 h, next transition milk feed at 
0800 h; and (4) calf born between 1500 and 0500 h, 
next transition milk feed at 0800. Time of birth of the 
calf was not associated with serum IgG concentration 
or AEA, and thus was not retained in the final models.
Calf PII. Concentration of iodine in calf plasma was 
normally distributed. Mixed models in PROC MIXED 
(SAS version 9.3) were used to determine the effect 
of experimental treatment on PII concentrations at 0 
and 24 h of age. Independent variables considered for 
inclusion in the model included experimental treatment 
group of the calf and age of the calf when plasma was 
sampled (0 and 24 h). Interactions between experimen-
Journal of Dairy Science Vol. 97 No. 8, 2014
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tal treatment group of calf and age of calf were also 
considered in the model. Calf was included as a repeated 
effect and heterogeneous variances were assumed among 
records. Orthogonal contrasts were used to compare (1) 
the HI_HI and HI_MI treatments combined, against 
the SI_SI treatment; (2) the HI_HI and HI_MI treat-
ments combined, against the HMI_HMI treatment;( 3) 
the HI_HI and HI_MI treatments combined, against 
the MI_MI and MI_HI treatments combined; (4) the 
MI_MI and MI_HI treatments combined, against the 
SI_SI treatment; and (5) the MI_MI and MI_HI treat-
ments combined, against the HMI_HMI treatment.
Calf Health Scores. Five calves left the farm before 
commencement of health score recording, thus health 
score data were unavailable for these calves. A total 
of 1,543 individual calf health scores from 123 calves 
were available for analysis. For each health aspect sepa-
rately, the probability of a calf having a higher welfare 
score (i.e., worse score) within the study period was 
modeled by ordinal regression in PROC GENMOD 
(SAS version 9.3) utilizing a cumulative logit link func-
tion and a multinomial distribution. Calf was included 
as a repeated effect. The model included experimental 
treatment group of calf. The number of days a calf was 
present in the study before it was weaned or sold was 
also included as a covariate in the model. Significance 
was declared at P < 0.05.
Disease.  Calf diseases recorded were pneumonia, di-
arrhea, and omphalophlebitis. A case of pneumonia was 
defined as a calf displaying increased respiratory rate 
and effort, pyrexia, copious bilateral nasal discharge, or 
repeated coughing (alone or in combination). A case of 
diarrhea was defined as a calf repeatedly passing loose 
or watery feces, with or without blood content. A case 
of omphalophlebitis was defined as a calf exhibiting a 
swollen and painful umbilicus, with or without exuda-
tion of pus. The number of times a calf was treated 
for a disease was recorded as never, once, twice, or 3 
times. The probability of a calf receiving treatment for 
any disease a greater number of times within the study 
period was modeled with ordinal regression in PROC 
GENMOD (SAS version 9.3) utilizing a cumulative 
logit link function and assuming a multinomial distri-
bution of the data. Experimental treatment of calf was 
included in the model. The number of days a calf was 
present in the study before it was weaned or sold was 
also included as a covariate in the model.
RESULTS
IgG Concentration of Colostrum of Cows  
and Colostrum Fed to Calves
The IgG concentration of the colostrum fed to calves 
did not differ (P > 0.05) between experimental groups. 
The mean concentration of IgG in the colostrum fed to 
all calves at the first feeding was 117.0 g/L (SD = 41.1 
g/L). The mean total mass of IgG fed in the first 24 
h of life to the calves in the 6 experimental treatment 
groups was 15.7 g/kg of BW (SD = 5.3) and did not 
differ (P = 0.257) between experimental groups.
Serum IgG and AEA
Age of calf when serum was sampled affected the 
concentration of IgG (P < 0.001). Mean concentration 
of IgG in serum at 0 h was 0.34 g/L (SE = 0.66) and 
at 24 h of age was 34.1 g/L (SE = 0.66). No effect (P 
= 0.227) of experimental treatment was observed on 
the concentration of IgG measured in serum (Table 3), 
and no effect (P = 0.319) of age of calf × treatment 
interaction was noted. The AEA did not differ between 
treatment groups (P > 0.05).
PII
The orthogonal contrasts show that calf PII at 0 h of 
age was affected by cow experimental treatment group 
(P < 0.05). The PII of calves born to dams in the HI 
treatment group (i.e., the PII of the HI_HI and HI_MI 
calf treatment groups combined; 987.2 μg/L) was 
greater than the PII of calves born to dams in the MI 
treatment group (i.e., the PII of the MI_MI and MI_HI 
calf treatment groups combined; 510.1 μg/L; P < 0.01), 
Table 3. Mean serum IgG (g/L) concentrations at 0 and 24 h of age for calves of the different experimental treatment groups 
Item Time
Experimental treatment1 P-value2
HI_HI MI_MI SI_SI HMI_HMI HI_MI MI_HI T A T × A
IgG (g/L) 0 h 0.5 (0.1) 0.3 (0.1) 0.3 (0.1) 0.2 (0.1) 0.2 (0.1) 0.5 (0.1) 0.227 <0.001 0.319
24 h 38.9 (2.3) 34.6 (2.2) 32.7 (2.3) 33.3 (2.4) 31.4 (2.3) 33.6 (2.3)    
1SE are in parentheses. HI_HI = high iodine; born to HI dams, fed HI colostrum; MI_MI = maintenance iodine; born to MI dams, fed MI co-
lostrum; SI_SI = standard iodine; born to SI dams, fed SI colostrum; HMI_HMI = high to maintenance iodine; born to HMI calves, fed HMI 
colostrum; HI_MI = high iodine crossover; born to HI dams, fed MI colostrum; MI_HI = maintenance iodine crossover; born to MI dams, fed 
HI colostrum.
2T = effect of experimental treatment group; A = calf age; T × A = interaction of calf experimental treatment group and age.
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as well as that of calves born to dams in the SI (585.2 
μg/L; P < 0.001) and HMI treatment groups (692.9 
μg/L; P < 0.05). Calf PII at 24 h of age was affected by 
cow experimental treatment group (P < 0.05). The PII 
of calves born to dams in the HI treatment group (i.e., 
the PII of the HI_HI and HI_MI calf treatment groups 
combined; 1218.5 μg/L) was greater than the PII of 
calves born to dams in the MI treatment group (i.e., 
the PII of the MI_MI and MI_HI calf treatment groups 
combined; 228.5μg/L; P < 0.001), as well as that of 
calves born to dams in the SI (302.2 μg/L; P < 0.001) 
and HMI treatment groups (320.7 μg/L; P < 0.001).
The effect of calf experimental treatment group on 
PII differed (P < 0.05) with the age of the calf (Fig-
ure 2). At 0 h of age, calves in the HI_HI treatment 
group had a greater concentration of PII (990.7 μg/L) 
than calves in the MI_MI (485.4 μg/L; P < 0.001), 
SI_SI (585.2 μg/L; P < 0.05) and MI_HI treatment 
groups (534.6 μg/L; P < 0.01), and tended to have 
a greater concentration of PII than calves in the 
HMI_HMI treatment group (692.9 μg/L; P = 0.07). 
Similarly, calves in the HI_MI treatment group had a 
greater concentration of PII (983.6 μg/L) than calves 
in the MI_MI, SI_SI and MI_HI treatment groups (P 
< 0.001, < 0.05, and < 0.001, respectively) and tended 
(P = 0.09) to have a greater concentration of PII than 
calves in the HMI_HMI treatment group. No difference 
was observed between the PII of calves in the HI_HI 
treatment group and calves in the HI_MI treatment 
group (P = 0.967).
At 24 h of age, the PII of calves in MI_MI, SI_SI, 
HMI_HMI, and MI_HI treatment groups decreased, 
but the PII of calves in the HI_HI and HI_MI treat-
ment groups did not. At 24 h of age, calves in the 
HI_HI treatment group had a greater concentration of 
PII (1259.2 μg/L) than calves in the MI_MI (240.7 
μg/L; P < 0.001), SI_SI (302.2 μg/L; P < 0.001), 
HMI_HMI (320.7 μg/L; P < 0.001), and MI_HI treat-
ment groups (216.3 μg/L; P < 0.001). Similarly, calves 
in the HI_MI treatment group had a greater concentra-
tion of PII (1,177.8 μg/L) than calves in the MI_MI, 
SI_SI, MI_HI, and HMI_HMI treatment groups (P < 
0.001 for all). No difference was noted between the PII 
of calves in the HI_HI treatment group and calves in 
the HI_MI treatment group (P = 0.610).
Disease
A total of 50 disease episodes (i.e., calf received treat-
ment for a disease) were recorded between January 24 
and June 19, 2012. We observed 25 cases of pneumonia, 
21 cases of diarrhea, 3 of omphalophlebitis (navel-ill), 
and 1 calf developed septicaemia. Twenty-seven calves 
had at least 1 disease episode. Experimental treatment 
of calf did not affect the probability of a calf receiving 
treatment for a disease a greater number of times (P = 
0.664). Six calves died during the study period: 3 calves 
from the MI_HI treatment, 2 calves from the HI_HI 
treatment, and 1 calf from the SI_SI treatment. One 
calf from the HI_HI treatment died of pneumonia and 1 
Figure 2. Mean plasma inorganic iodine (PII; μg/L) concentrations at 0 and 24 h of age for calves of the HI_HI, MI_MI, SI_SI, HMI_HMI, 
HI_MI and MI_HI experimental treatment groups. HI = high iodine; MI = maintenance iodine; SI = standard iodine; HMI = high to main-
tenance iodine; HI_HI = born to HI dams, fed HI colostrum; MI_MI = born to MI dams, fed MI colostrum; SI_SI = born to SI dams, fed SI 
colostrum; HI_MI = born to HI dams, fed MI colostrum; MI_HI = born to MI dams, fed HI colostrum; HMI_HMI = born to HMI dams, fed 
HMI colostrum.
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died from complication of omphalophlebitis. Two calves 
from the MI_HI treatment died of pneumonia and 1 
calf died of diarrhea. The calf from the SI_SI treatment 
was euthanized because it had atresia coli.
Health Scores
The overall prevalence of scores indicating normal 
health was high; 81.5, 87.2, 92.4, and 92.7% of the 
scores were zero (i.e., normal health) for nasal, eye 
and ear, cough, and fecal consistency aspects of health. 
Scores of 2 and 3 were assigned for 14 and 4% of nasal 
scores, 10 and 2% of eye and ear scores, 4 and 3% of 
cough scores, and 5 and 2% of fecal consistency scores, 
respectively. Less than 1% of scores assigned were in-
dicative of severely abnormal health (i.e., score of 3). 
Experimental treatment had no effect on the likelihood 
of a calf being assigned a worse nasal (P = 0.366), eye 
and ear (P = 0.704), cough (P = 0.875), or fecal (P = 
0.958) score within the study period.
DISCUSSION
Effect of Iodine Supplementation of Cows  
on IgG Absorption in Calves
In the present study, feeding cows varying levels of 
supplementary iodine during the 7-wk precalving pe-
riod had no effect on the IgG absorption efficiency or 
level of IgG measured in the serum of their calves at 
24 h of age. This is a similar result to those reported in 
previous studies undertaken in cattle; Rose et al. (2012) 
reported that the administration of a bolus containing 
6,800 mg of iodine to 25 nonlactating Holstein-Friesian 
dairy cows approximately 8 wk before parturition had 
no effect on the plasma concentration of IgG or on the 
efficiency of absorption of IgG by calves during the first 
day of life. Serum IgG concentration at 24 h of age 
of calves born to supplemented dams (15.5 g/L) was 
not different to that of calves born to unsupplemented 
dams (13.4 g/L). Similarly, Gilles et al. (2009) reported 
no difference in IgG concentration measured in calf 
serum at 24 to 36 h of age between calves born to 
dams supplemented with a bolus containing 1,200 mg 
of iodine 20 to 35 d before the parturition due date 
(25.1 g/L) and calves born to unsupplemented cows 
(19.8 g/L). The present study is the first, to our knowl-
edge, that has examined the effects of offering bovine 
animals varying levels of iodine supplementation using 
a mineral powder. The results of the present study and 
the studies mentioned herein are in contrast to previous 
research carried out in sheep, which reported that feed-
ing a high level of iodine in the prepartum diet to ewes 
can indeed reduce serum IgG concentration and IgG 
absorption efficiency in the lamb (Boland et al., 2004, 
2005a,b; Crosby et al., 2004).
It is unclear at present why this discrepancy in re-
sults between cows and sheep exists. Prior to the pres-
ent study, it was plausible that the level of iodine fed 
in the studies by Gilles et al. (2009) and Rose et al. 
(2012) were simply not high enough to cause the ef-
fect on serum IgG concentration reported in sheep. The 
levels of iodine delivered to the cows in the studies by 
Rose et al. (2012) and Gilles et al. (2009) on a daily 
basis by the bolus [56.7 and 43.6 mg/d (equivalent to 
0.44 and 0.36 mg/kg0.75 per day, respectively)] were 
lower than the level previously demonstrated to cause 
a reduction in colostral IgG absorption in sheep (14.8 
mg/d, equivalent to 0.62 mg/kg0.75 per day; Rose et 
al., 2007). In fact, the level of iodine delivered to the 
cows in both studies was likely to have been much lower 
toward the end of the supplementation period, as the 
release of minerals from boluses appears not to be con-
stant (Watson et al., 2012); rather, the release is much 
greater following initial insertion and much less as the 
boluses age. Rose et al. (2012) postulated that perhaps 
a similar reduction in the IgG absorption by the calves 
would have occurred had the cows in their study been 
supplemented with iodine at a greater rate. However, 
the cows in the HI precalving experimental treatment 
group in the present study were supplemented with 162 
mg/d (equivalent to 1.34 mg/kg0.75 per day), delivered 
at a consistent daily rate via a powder. This is over 2 
times greater than the level shown to cause an effect in 
sheep per unit of metabolic live weight, and, yet, still 
did not have any effect on the IgG status of the calves.
It is possible that iodine exerts a different effect on 
the biological pathways that mediate the intestinal ab-
sorption of IgG in the neonate, specifically the thyroid 
hormones. Iodine is necessary for the synthesis of the 
thyroid hormones, thyroxine and triiodothyonine (T3), 
which regulate energy metabolism (NRC, 2001) and 
have numerous functions as regulators of cell activity 
and growth. Earlier work has indicated a relationship 
between the concentration of thyroid hormones in the 
immediate prepartum period and the transmission of 
IgG in the neonate; greater levels of T3 increase IgG 
absorption in both lambs (Boland et al., 2008) and 
calves (SlebodziĔski et al., 1995; Rose et al., 2012). 
However, whereas a high level of supplementary iodine 
offered to prepartum ewes reduced T3 in lambs (Boland 
et al., 2008), the same did not occur in calves (Rose 
et al., 2012). Thus, it appears that thyroid hormones 
are related to IgG absorption in both cows and sheep, 
but that iodine affects the concentration of thyroid 
hormones in sheep in a way that it perhaps does not 
in cattle. This is an area that warrants further detailed 
research.
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Adequate passive transfer is critical to ensure the 
calf has adequate immune defenses to protect it from 
disease until development of its own immunity occurs 
at 3 to 4 wk of age (Godden, 2008). Given the high 
IgG concentration of the colostrum fed to calves in the 
present study (117 g/L), their high serum IgG level is 
to be expected, as concentration of IgG in colostrum 
is a critical factor in ensuring adequate absorption by 
the calf (Pritchett et al., 1991). Furthermore, all calves 
were fed a large volume of colostrum very early follow-
ing birth; this also undoubtedly contributed to their 
high absorption of IgG, as both volume (Godden, 2008) 
and time of ingestion (Stott et al., 1979) of colostrum 
are important factors in determining the concentration 
of IgG achieved in calf serum. In the study by Rose 
et al. (2012), calves received colostrum of a lower IgG 
concentration (mean 74.5 g/L) and only received 4.5% 
of their BW at the first feed compared with the calves 
in the present study, who received 8.5%. The calves in 
the study of Rose et al. (2012) received an average total 
of 367 g of IgG within the first 24 h of life; calves in the 
present study received 53% more. The comparatively 
greater serum IgG concentration at 24 h in the calves of 
the present study is a reflection of the greater quantity 
of IgG available to the calves. Gilles et al. (2009) did 
not measure the IgG concentration of the colostrum 
that was fed to the calves in their study, or control the 
quantity of colostrum that was ingested.
It may be that a high level of iodine supplementation 
in the diet of prepartum cows would have resulted in a 
reduction in absorption efficiency of IgG of their calves 
only when the amount of IgG available for absorption 
from colostrum was lower than that of the current 
study. In the present study, colostral IgG concentration 
was not determined before feeding it to calves, and sub-
sequent analysis revealed that the mean IgG delivered 
to the calves was high (an average of 563.1g of IgG 
was delivered to each calf). Approximately only 150 
to 200 g of total IgG is required for adequate passive 
transfer in calves (Chigerwe et al., 2008). It is possible 
that AEA may have been affected at lower IgG concen-
trations, but the design of the current study did not 
allow for detection of this. This is an area that warrants 
further research.
In the present study, considering that no difference 
in serum IgG at 24 h of age was noted between experi-
mental groups and, as such, all calves had the same de-
gree of protection from disease, it is unsurprising that 
experimental treatment group of calf had no effect on 
any of the health scores measured, or on the likelihood 
of a calf receiving treatment for a disease during the 
study period. Boland et al. (2008) reported a greater 
level of upper tail or anal region fecal soiling in lambs 
born to dams supplemented with a high level of iodine 
compared with lambs born to unsupplemented ewes. 
Lambs born to dams supplemented with a high level of 
iodine had a reduced serum IgG absorption efficiency 
and serum IgG concentration at 24 h, and it was sug-
gested that the greater fecal soil scores were perhaps 
due to a breakdown in the digestive process in the gut 
of these lambs, resulting in an increased rate of passage 
of colostrum through the intestine of these lambs. No 
such response was observed in the present study.
Earlier work in sheep has demonstrated that the 
timing of the iodine supplementation is important in 
relation to reducing IgG absorption of the progeny 
(Boland et al. 2008), with a high level of supplemen-
tation during the final week alone sufficient to cause 
a reduction in absorption. In the present study, the 
timing of supplementation had no effect on the level of 
IgG absorption in the calf. If, as the results of the pres-
ent study would suggest, iodine supplementation does 
not cause a reduction in the IgG absorption efficiency 
in cattle in the same way it has been documented in 
sheep, then the fact that the timing of supplementation 
had no effect is to be expected.
Effect of Iodine Supplementation  
of Cows on PII of Calves
Whereas varying the level of iodine supplementation 
of dams in the precalving period did not affect the abil-
ity of the calves to absorb IgG, it did affect the levels of 
circulating iodine in the plasma of the calves. The high 
level of iodine fed to the cows in the HI treatment group 
was reflected in the greater concentration of iodine in 
the plasma of calves of both the HI_HI and the HI_MI 
treatment groups when sampled at 0 h of age. Circulat-
ing iodine in the pregnant cow is readily transported to 
the bovine fetus (Aschbacher et al., 1966; Miller et al., 
1967; Guyot et al., 2011), and thus the high level of PII 
in the HI_HI and the HI_MI calves is not surprising.
Consistent with previous studies (Miller et al., 1967; 
Gilles et al., 2009), PII levels declined between 0 h and 
24 h of age by 50, 50, 54, and 59% for calves in the MI_
MI, SI_SI, HMI_HMI, and MI_HI treatment groups, 
respectively. Whereas the PII of calves in the HI_HI 
and the HI_MI treatment groups increased between 0 
and 24 h of age, the difference between PII at 0 and 24 
h was not significant for these groups, and the numeri-
cal increase could be a chance result attributable to the 
vagaries of the testing method.
In evaluating the iodine status of cattle, a PII be-
tween 106 and 285 μg/L is considered adequate, and 
less than 50 μg/L appears to be deficient (Mee and 
Rogers, 1996). Iodine deficiency in the pregnant cow or 
heifer can result in the birth of goitrous, weak, hairless, 
or dead calves (Hidiroglou, 1980; NRC, 2001). None of 
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the calves in the present study were born as such. It 
appears no PII levels have been defined as adequate 
for neonatal calves at present; however, considering the 
levels currently established for adult cattle, none of the 
calves were deemed deficient in iodine at either 0 or 24 
h of age. In fact, at 0 h of age, all calves had a PII that 
exceeded the level defined as adequate. The PII at 0 h 
in calves of dams that received no additional supple-
mentation was more than adequate, and therefore the 
results of the current study indicate that ensuring the 
diet of the precalving cow meet the minimum NRC re-
quirements for the pregnant, nonlactating cow is suffi-
cient to ensure the appropriate iodine status and health 
of the newborn calf, and that supplementing additional 
iodine is unnecessary for this purpose. However, the 
effects on the cow were not established as part of this 
present study, and this is an area that warrants further 
research.
Practical Implications
Although the results of the current study suggest 
that over-supplementation of iodine in the precalving 
period does not affect the passive transfer of immunity 
to calves, we would urge producers not to interpret this 
as an encouragement to feed large quantities of iodine. 
Supplementation of the prepartum dairy cow with io-
dine above the level necessary to meet the minimum 
requirements established by the NRC was unnecessary 
to ensure appropriate iodine levels in calves at birth. In 
addition to being financially wasteful, few proven ben-
efits exist to feeding more iodine than recommended, 
and iodine toxicity (which has been reported in adult 
dairy cows with dietary intakes of just 50 mg/d; NRC, 
2001) can result in many deleterious outcomes. These 
include excessive nasal and ocular discharge, salivation, 
decreased milk production, coughing, and dry, scaly 
coats (Olson et al., 1984), an increase in reproductive 
disorders (Paulíková et al., 2002), and suppression of 
the immune system (Hillman and Curtis, 1980), pos-
sibly resulting in reduced ability to combat disease 
(Olson et al., 1984). The present study is one of only a 
limited number of studies carried out to investigate the 
effects of high iodine supplementation of the dairy cow 
on the IgG absorption in her calves, and further work 
in this area is warranted.
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